Vista Current Coverage

All Atossa Genetics, Inc. Articles

Sarepta Announces Positive Results…Shares Rise

Sarepta Therapeutics, Inc. (SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases, today announced muscle biopsy results from its 4053-101 study, a Phase 1/2 first-in-human study conducted in Europe to assess the safety, tolerability,...

“Meeting or Exceeding Expections”

Vista Partners (“Vista”) has published its FREE Macroeconomic & Investment Monthly Newsletter for the month of August. Each monthly newsletter from Vista contains macroeconomic thoughts, investment considerations with regard to Biotechnology, Cloud Services, Energy, Fintech, Healthcare Insurance, Manufacturing, SaaS, & Technology, monthly highlights from select...